Related Experiment Video
Updated: Jul 4, 2026
07:49
Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Tumor cell phenotype is sustained by selective MAPK oxidation in mitochondria
Soledad Galli1, Valeria Gabriela Antico Arciuch, Cecilia Poderoso
1Laboratory of Oxygen Metabolism, University Hospital, University of Buenos Aires, Buenos Aires, Argentina.
Plos One
|June 12, 2008
Summary
Mitochondrial hydrogen peroxide (H(2)O(2)) levels regulate cell proliferation by controlling mitogen-activated protein kinase (MAPK) activity. Tumor cells with defective mitochondria maintain proliferation due to disrupted H(2)O(2) signaling.
Area of Science:
- Cell Biology
- Biochemistry
- Cancer Research
Background:
- Mitochondria are key producers of hydrogen peroxide (H(2)O(2)), influencing cell phenotypes.
- Elevated H(2)O(2) can halt proliferation, while low levels in tumors may sustain it.
- Mitogen-activated protein kinases (MAPKs) are redox-sensitive signaling molecules found in mitochondria.
Purpose of the Study:
- To investigate the link between tumor mitochondrial dysfunction, H(2)O(2) production, and MAPK activation.
- To elucidate the role of H(2)O(2) levels in regulating cell cycle transitions via MAPK signaling.
- To understand how mitochondrial defects contribute to sustained tumor cell proliferation.
Main Methods:
- Confocal microscopy and in vivo imaging of LP07 murine tumor cells.
- Directed mutagenesis to study redox-sensitive cysteine domains in MAPKs.
- Mass spectrometry to analyze MAPK-MAPKK interactions and cysteine oxidation states.
Main Results:
- Low H(2)O(2) (1 microM) promoted proliferation via ERK1/2 activation, while high H(2)O(2) (50 microM) arrested the cell cycle through p38 and JNK1/2.
- MAPK activation and nuclear translocation were dependent on H(2)O(2)-induced oxidation of specific cysteine residues.
- Mutation of ERK2 Cys(214) impaired MEK1/2 binding, caused ERK2 retention in mitochondria, and blocked nuclear signaling.
Conclusions:
- Selective oxidation of MAPK cysteine domains by H(2)O(2) regulates MAPK-MAPKK interactions and subcellular localization.
- Dysfunctional tumor mitochondria fail to produce sufficient H(2)O(2), disrupting MAPK signaling and promoting uncontrolled proliferation.
- Targeting mitochondrial H(2)O(2) production or MAPK redox regulation may offer therapeutic strategies for cancer.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...